NeuroOne Medical Technologies Corp To Discuss its Business Operations and Recent Updates Transcript - Thomson StreetEvents

NeuroOne Medical Technologies Corp To Discuss its Business Operations and Recent Updates Transcript

NeuroOne Medical Technologies Corp To Discuss its Business Operations and Recent Updates Transcript - Thomson StreetEvents
NeuroOne Medical Technologies Corp To Discuss its Business Operations and Recent Updates Transcript
Published Oct 07, 2025
10 pages (4636 words) — Published Oct 07, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of NMTC.OQ conference call or presentation 7-Oct-25 12:30pm GMT

  
Brief Excerpt:

...Operator Good day, ladies and gentlemen, and welcome to the NeuroOne Medical Technologies Corporation virtual webinar. Today's call will be conducted by the company's Chief Executive Officer, Dave Rosa; and Ron McClurg, the company's Chief Financial Officer. Before I turn the call over to Mr. Rosa, I'd like to remind you that this conference call will include forward-looking statements within the meaning of US federal securities laws with respect to future operations, financial results, events, trends, and performance, which are based on management's beliefs and assumptions as of today's call. Forward-looking statements, including statements regarding our fiscal 2025 preliminary product revenue, may involve known and unknown risks, uncertainties, and other factors which may cause actual results to differ materially from those expressed or implied by such statements. See NeuroOne's financial results, press releases, and SEC filings for information regarding specific risks and uncertainties...

  
Report Type:

Transcript

Source:
Company:
Neuroone Medical Technologies Corp
Ticker
NMTC.OQ
Time
12:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Jeffrey Cohen - Ladenburg Thalmann & Co Inc - Analyst : Oh hey, Dave and Ron, thanks for taking our questions. LSEG STREETEVENTS | www.lseg.com | Contact Us consent of LSEG. 'LSEG' and the LSEG logo are registered trademarks of LSEG and its affiliated companies. OCTOBER 07, 2025 / 12:30PM, NMTC.OQ - NeuroOne Medical Technologies Corp To Discuss its Business Operations and Recent Updates


Question: Jeffrey Cohen - Ladenburg Thalmann & Co Inc - Analyst : My pleasure. Ron, just a quick one, the [6.6%] of cash from the end of September, does that include the $3 million Zimmer as well?


Question: Jeffrey Cohen - Ladenburg Thalmann & Co Inc - Analyst : Got it. Can you talk a little bit about the face to-- face pain [510k congrats] on getting it and as far as getting commercial on it. Are you thinking about direct or you're thinking about partnerships at least domestically?


Question: Jeffrey Cohen - Ladenburg Thalmann & Co Inc - Analyst : Okay, and Dave, how many cases do you think will be performed through the balance of this year?


Question: Jeffrey Cohen - Ladenburg Thalmann & Co Inc - Analyst : Okay, got it. I guess back to you, Ron, it looks like. Q4 was nearly a million dollars higher than Q3. So, maybe talk about what drove that in particular and what kind of pull through we'll see into '26. LSEG STREETEVENTS | www.lseg.com | Contact Us consent of LSEG. 'LSEG' and the LSEG logo are registered trademarks of LSEG and its affiliated companies. OCTOBER 07, 2025 / 12:30PM, NMTC.OQ - NeuroOne Medical Technologies Corp To Discuss its Business Operations and Recent Updates


Question: Jeffrey Cohen - Ladenburg Thalmann & Co Inc - Analyst : Okay, got it. And one more, if I may, you spoke a little bit about drug delivery with pharmaceuticals. Could you give us a sense of perhaps drug volumes or perhaps locations of the body?


Question: Jeffrey Cohen - Ladenburg Thalmann & Co Inc - Analyst : Okay, that's helpful. And any sense on timing on the k to be filed?


Question: Jeffrey Cohen - Ladenburg Thalmann & Co Inc - Analyst : Got it. Okay, perfect, thanks for taking that questions. LSEG STREETEVENTS | www.lseg.com | Contact Us consent of LSEG. 'LSEG' and the LSEG logo are registered trademarks of LSEG and its affiliated companies. OCTOBER 07, 2025 / 12:30PM, NMTC.OQ - NeuroOne Medical Technologies Corp To Discuss its Business Operations and Recent Updates


Question: Anthony Vendetti - Maxim Group LLC - Analyst : Thank you. Yeah, so I just wanted to talk a little bit about the quarter and Dave, you said the momentum you're seeing from this quarter. You think will continue, in terms of the pipeline for fiscal year '26. Is the momentum you're seeing. Just based on patient volume, on the-- what you're seeing from or hearing from the physicians, and then I know it's a multi-part question. But, when you look at where this is coming from. Obviously, it's mostly coming from the physicians, but our patients becoming also more aware of your offering and if so, how?


Question: Anthony Vendetti - Maxim Group LLC - Analyst : Okay, great. That makes a lot of sense. And then on the on the reimbursement process, how are you how are you assisting the physicians. With that particular piece of it. LSEG STREETEVENTS | www.lseg.com | Contact Us consent of LSEG. 'LSEG' and the LSEG logo are registered trademarks of LSEG and its affiliated companies. OCTOBER 07, 2025 / 12:30PM, NMTC.OQ - NeuroOne Medical Technologies Corp To Discuss its Business Operations and Recent Updates


Question: Anthony Vendetti - Maxim Group LLC - Analyst : Okay, Is there anything else about the onboarding process or physician support. Other than, these associations are going forward to recruit other physicians, make them more aware of it, whether it's-- you have more salespeople, but there's there any other, social media way of reaching out and making everyone more aware of it whether it's like you said individuals certainly, yeah, go ahead.


Question: Anthony Vendetti - Maxim Group LLC - Analyst : Okay, great, that's-- thanks for all the call that was very helpful. I'll hop back in the queue.


Question: Jeffrey Cohen - Ladenburg Thalmann & Co Inc - Analyst : Sorry, I thought of one more. Dave, could you talk a little bit about the thin-film development and thin-film technology and your partnership there and what we may see over, throughout 2026. LSEG STREETEVENTS | www.lseg.com | Contact Us consent of LSEG. 'LSEG' and the LSEG logo are registered trademarks of LSEG and its affiliated companies. OCTOBER 07, 2025 / 12:30PM, NMTC.OQ - NeuroOne Medical Technologies Corp To Discuss its Business Operations and Recent Updates


Question: Jeffrey Cohen - Ladenburg Thalmann & Co Inc - Analyst : Super, thanks for taking that thanks.

Table Of Contents

NeuroOne Medical Technologies Corp Q4 2025 Earnings Call Transcript – 2025-12-17 – US$ 54.00 – Edited Transcript of NMTC.OQ earnings conference call or presentation 17-Dec-25 1:30pm GMT

NeuroOne Medical Technologies Corp Q2 2025 Earnings Call Transcript – 2025-05-13 – US$ 54.00 – Edited Transcript of NMTC.OQ earnings conference call or presentation 13-May-25 12:30pm GMT

NeuroOne Medical Technologies Corp Q1 2025 Earnings Call Transcript – 2025-02-12 – US$ 54.00 – Edited Transcript of NMTC.OQ earnings conference call or presentation 12-Feb-25 1:30pm GMT

Preliminary Q1 2025 Neuroone Medical Technologies Corp Earnings Call Transcript – 2025-01-10 – US$ 54.00 – Edited Transcript of NMTC.OQ earnings conference call or presentation 10-Jan-25 4:00pm GMT

Neuroone Medical Technologies Corp Q4 2024 Earnings Call Transcript – 2024-12-17 – US$ 54.00 – Edited Transcript of NMTC.OQ earnings conference call or presentation 17-Dec-24 2:00pm GMT

Neuroone Medical Technologies Corp At Virtual Investor Summit Microcap Event Transcript – 2024-11-21 – US$ 54.00 – Edited Transcript of NMTC.OQ corporate analyst meeting</ 21-Nov-24 6:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "NeuroOne Medical Technologies Corp To Discuss its Business Operations and Recent Updates Transcript" Oct 07, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/NeuroOne-Medical-Technologies-Corp-To-Discuss-its-Business-Operations-and-Recent-Updates-T16604563>
  
APA:
Thomson StreetEvents. (2025). NeuroOne Medical Technologies Corp To Discuss its Business Operations and Recent Updates Transcript Oct 07, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/NeuroOne-Medical-Technologies-Corp-To-Discuss-its-Business-Operations-and-Recent-Updates-T16604563>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.